Skip to content
Research Article Open access CC BY 4.0

Clinical Significance of Creatine Kinase-MB Elevation in Patients with Chronic Kidney Disease before Initiation of Hemodialysis

Ehimen Phyllis Odum, Victor Chukwuma Wakwe

Cardiology and Angiology: An International Journal · pp. 1–7 · Published 5 Dec 2017

10.9734/CA/2017/38020

Abstract

Aim: To measure creatine kinase – myocardial band (CK-MB) concentration in stable patients with chronic kidney disease who had not commenced hemodialysis and determine its relationship with cardiac Troponin I and cardiovascular risk factors. Study Design: Cross-sectional study. Place and Duration of Study: Renal Unit, Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Rivers State, Nigeria from January 2014 to December 2015. Methodology: Blood pressure, serum CK-MB, cardiac Troponin I, HDL-cholesterol, total cholesterol, triglyceride, fasting plasma glucose, urine and serum albumin, urine and serum creatinine concentrations were analysed in 83 diagnosed chronic kidney disease patients attending the renal clinic and 83 age- and sex-matched healthy control subjects. Body mass index (BMI), estimated GFR (eGFR), urinary albumin-creatinine ratio (UACR) and LDL-cholesterol were calculated.  Results: CKD patients had higher CK-MB, higher cardiac troponin I, higher blood pressure, higher serum creatinine, higher triglyceride, higher UACR, lower serum albumin, lower HDL and lower eGFR compared to controls. Sixteen (19.3%) patients versus 11 (13.3%) controls had elevated CK-MB. Among patients, CK-MB was positively associated with UACR, low HDL and dyslipidemia but not associated with cardiac Troponin I. Conclusion: CK-MB elevation was associated with albuminuria, low HDL and dyslipidemia. However, CK-MB lacked association with cardiac troponin I, which is a more cardiac-specific biomarker. This shows that serum CK-MB levels may not be suitable for diagnosing myocardial injury in CKD patients.  

Creatine kinase – MB chronic kidney disease cardiovascular disease UACR albuminuria

References (16)

  1. 1 Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge [DOI]
  2. 2 A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation [DOI]
  3. 3 Troponin: the biomarker of choice for the detection of cardiac injury [DOI]
  4. 4 Plasma 99th Percentile Reference Limits for Cardiac Troponin and Creatine Kinase MB Mass for Use with European Society of Cardiology/American College of Cardiology Consensus Recommendations [DOI]
  5. 5 Prevalence of chronic kidney disease in a Nigerian family practice population [DOI]
  6. 6 Comparison of the Prognostic Value of Peak Creatine Kinase‐MB and Troponin Levels Among Patients With Acute Myocardial Infarction: A Report from the Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines [DOI]
  7. 7 Cardiovascular Biomarkers in Chronic Kidney Disease: State of Current Research and Clinical Applicability [DOI]
  8. 8 Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention.
  9. 9 Increased creatine kinase MB in the absence of acute myocardial infarction. [DOI]
  10. 10 Cardiac Enzymes, Renal Failure and Renal Transplantation [DOI]
  11. 11 Comparison of C‐reactive Protein and Albumin Excretion as Prognostic Markers for 10‐Year Mortality After Myocardial Infarction [DOI]
  12. 12 Gender differences in serum CK-MB mass levels in healthy Braziliansubjects [DOI]
  13. 13 The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST [DOI]
  14. 14 Cardiac troponin-T and CK-MB (mass) levels in cardiac and non cardiac disease [DOI]
  15. 15 Cardiac markers used in the detection of myocardial injury [DOI]
  16. 16 Evaluation of Cardiac Markers in Chronic Renal Failure [DOI]

Cited by 4

Kidney disease and hemodialysis: identification of blood biomarkers to detect heart failure and kidney failure

B. Mayer, Pollyana Thays Lameira da Costa, M. E. Echevarría-Guanilo · Revista Colombiana de Nefrología · 2020

Enzymes as Diagnostic Tools

R. Singh, Taranjeet Singh, A. Singh · Advances in Enzyme Technology · 2019

Showing 3 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

74

Page views

0

PDF downloads

26

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.